About Us
About hVIVO
Leadership Team
Our Companies
History
Services
Human Challenge Trials
RSV
Influenza
COVID-19
HRV
Malaria
Asthma & COPD
hMPV
Laboratory Services
Clinical Trial Recruitment
Clinical Trial Site Services
Vaccine Phase II-III Trials
Respiratory Clinical Trials
Specialised Renal and Hepatic Impairment Trials
Articles & Research
News & Media
Regulatory News
Media Coverage
Media Press Kit
Media Library
Events
Investors
Investors
Regulatory News & Email Alerts
Results Centre
Share Price Information
Events & Presentations
ESG
AIM Rule 26
Advisors
Documents
Corporate Governance
Volunteers
Careers
Contact Us
Contact Us
Articles & Research
from hVIVO
Article Types Filter
Article Types Filter
Blog
Presentation
Article
Scientific Paper
Factsheet
Abstract
Case Study
Article Count
1 - 10 of 79 posts
Scientific Paper
14 Jun 2023
Viral emissions into the air and environment after SARS-CoV-2 human challenge: a phase 1, open label, first-in-human study
Effectively implementing strategies to curb SARS-CoV-2 transmission requires understanding who is contagious and when. Although viral load on upper respiratory swabs has commonly been used to infer contagiousness, measuring viral...
View Link
Blog
12 Jun 2023
Why are Biotech’s & Pharma Using Human Challenge Studies for Drug Development?
What is a human challenge study? In a human challenge study, healthy volunteers are intentionally infected with a virus/bacteria or parasite in a quarantine facility. The volunteers are monitored under...
Read more
Article
22 Mar 2023
Utilising Human Challenge Trials as a tool in expedited review programs for infectious diseases
Featured on pages 18-19
View Link
Blog
20 Mar 2023
Advantages to Centralising Laboratory Services at hVIVO
Clinical field studies are a critical part of the drug development and approval process. They are conducted to evaluate the safety, immunogenicity, and efficacy of a new drug. These studies...
Read more
Blog
07 Mar 2023
EMA’s updated guideline to include broader coverage on Human Challenge Trials
View Link
Blog
20 Feb 2023
Advantages of Human Challenge Studies (Part 1)
Human challenge studies or controlled human infection model (CHIM) studies are Phase Ib or Phase IIa clinical trials, in which study participants, i.e. healthy volunteers, are deliberately exposed to infectious...
Read more
Article
07 Feb 2023
Accelerated regulatory pathways: Vaccines for tropical diseases
View Link
Article
24 Nov 2022
Human Clinical Trials: A Tool in the Fight Against Infectious Diseases
In the wake of the COVID-19 pandemic, research into infectious diseases remains an integral and growing avenue of clinical research. What benefits can Human Challenge Trials have for clinicians exploring...
Read more
Presentation
03 Oct 2022
RSV Vaccines/Prophylactics: Key learnings from the RSV challenge model and efficacy of vaccines
Challenge studies can be a powerful tool in the development of both therapeutic agents and vaccines. However, key decisions made in the study design process can have a profound impact...
Read more
Presentation
03 Oct 2022
Initial characteristics of respiratory viruses in symptomatic subjects during the pandemic, a cohort study
During the most intense waves of the recent pandemic, we have witnessed a clear and almost complete wipe-out of many respiratory viruses routinely circulating in the community over the north-hemisphere...
Read more
Article Pagination
1
2
3
…
7
8
Next »
Articles Per Page
Articles Per Page
8
10
16
24
32
Stay connected
Sign up to our emails and follow us on social media to keep up to date with hVIVO.
Comments
By clicking Sign Up you're confirming that you agree with our
Privacy Policy
.
angle-down
meetup
chevron-down
arrow-up